Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NICE
Pharma
England is not attractive place for investment, Lilly CEO says
In an interview with the Financial Times, Eli Lilly CEO David Ricks has called England “probably the worst country in Europe” for drug pricing.
Kevin Dunleavy
Sep 24, 2025 10:52am
BMS will charge same price in UK as its does in US for Cobenfy
Sep 22, 2025 12:05pm
NICE again rejects Alzheimer's drugs from Lilly and Biogen/Eisai
Mar 6, 2025 10:47am
NICE says AZ, Daiichi failed to propose fair price on Enhertu
Nov 19, 2024 11:08am
England's NICE not sold on Lilly's Kisunla despite UK approval
Oct 23, 2024 11:00am
NHS England proposes phased rollout for Lilly's obesity med
Oct 3, 2024 3:22pm
